# Can Platelets/Lymphocytes Rate Be New Serological Index for Prognosis of Coronary Heart Disease Complicated With Impaired Glucose Tolerance: Basic Principles and Experimental Design

> **NCT02149056** · — · COMPLETED · sponsor: **Affiliated Hospital of Hebei University** · enrollment: 447 (actual)

## Conditions studied

- Coronary Heart Disease Complicated With Impaired Glucose Tolerance

## Interventions

- **BEHAVIORAL:** observation
- **OTHER:** Impaired Glucose Tolerance

## Key facts

- **NCT ID:** NCT02149056
- **Lead sponsor:** Affiliated Hospital of Hebei University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 447 (ACTUAL)
- **Last updated:** 2014-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02149056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02149056, "Can Platelets/Lymphocytes Rate Be New Serological Index for Prognosis of Coronary Heart Disease Complicated With Impaired Glucose Tolerance: Basic Principles and Experimental Design". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02149056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*